Is Nano-X Imaging Ltd. (NNOX) a good stock to buy?

Olyth's institutional analysis of NNOX reveals an Altman Z-Score of 0.73 and a Piotroski F-Score of 3/9. These metrics, combined with its 5-year revenue trend ($0.01B most recent), help investors decide if NNOX fits their risk profile.

What is the current P/E ratio for NNOX?

As of the latest trading session, Nano-X Imaging Ltd. (NNOX) has a trailing P/E ratio of -2.78.

Who is the CEO of Nano-X Imaging Ltd.?

The current Chief Executive Officer of Nano-X Imaging Ltd. is Erez I. Meltzer.

What was NNOX's revenue for the last 5 years?

According to its latest income statements, Nano-X Imaging Ltd. reported annual revenues of $0.01B (2024), $0.01B (2023), $0.01B (2022), $0.00B (2021), $0.00B (2020) respectively.

Does NNOX pay a dividend?

Nano-X Imaging Ltd. does not currently pay a dividend to its shareholders.

How much debt and cash flow does NNOX have?

In its latest reporting period, Nano-X Imaging Ltd. generated $-0.04B in Free Cash Flow against a total debt load of $0.01B.

What is the Price-to-Book (P/B) ratio of Nano-X Imaging Ltd.?

The Price-to-Book (P/B) ratio for Nano-X Imaging Ltd. (NNOX) is currently 0.99.

What is the Price-to-Sales (P/S) ratio of NNOX?

Based on trailing twelve-month data, Nano-X Imaging Ltd. (NNOX) trades at a Price-to-Sales (P/S) ratio of 12.49.

What is Nano-X Imaging Ltd.'s Return on Equity (ROE)?

Nano-X Imaging Ltd. (NNOX) has a Return on Equity (ROE) of -32.46%, representing its profitability relative to shareholder equity.

NNOX

Nano-X Imaging Ltd. · Healthcare

2.41

0.00%(+0.00)

Market Closed

2.65

9.96%(+0.24)

After Hours

Last Updated: — ET

52W L: $2.1152W H: $5.86

$2.42

CHG-0.23 (-8.68%)

H$2.78

L$2.12

VOL12M

NNOX (1h)

Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.

Sector

Healthcare

Industry

Medical - Devices

Employees

165

IPO Date

2020-08-21

Beta

1.38

Websitewww.nanox.vision↗

NNOX

Nanox Signs Distribution Agreement with Integrity Medical Service, Inc. to Deploy Nanox.ARC Systems

All You Need to Know About NanoX Imaging (NNOX) Rating Upgrade to Buy

Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina

Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems